← Snapshot 21

Orange Book snapshot 21: Products

Products page 167 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
8302N050141001PENICILLIN G BENZATHINEINJECTABLE;INJECTIONINJECTABLEINJECTIONBICILLIN L-AKING PHARMS LLC600,000 UNITS/MLBC["BC"]Approved Prior to Jan 1, 1982YesYesYesRXKING PHARMACEUTICALS LLC4eb7bdc03c765c6004af1178bc848e354df2cd9b2b27c5676a85106a58c9280f
8303N050131001PENICILLIN G BENZATHINEINJECTABLE;INJECTIONINJECTABLEINJECTIONBICILLIN L-AWYETH AYERST300,000 UNITS/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNWYETH AYERST LABORATORIEScd9487a6538a95381aa1d1cb551a3aadbbec1c247a0904fbf9ad221aaff784df
8304N017422001CARMUSTINEINJECTABLE;INJECTIONINJECTABLEINJECTIONBICNUEMCURE PHARMS LTD100MG/VIALAP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXEMCURE PHARMACEUTICALS LTDc98a690a230b7b16986aff3c08a37aca9a3d09923fcfb564a9f619ddf2adab41
8305N050443001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLENOXANEBRISTOL MYERS SQUIBBEQ 15 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNBRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE2a9a74b6c2d8aff009322709d1fccea84725681ee60b2dbdf7d415906e4aeae8
8306N050443002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLENOXANEBRISTOL MYERS SQUIBBEQ 30 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1995-09-07Sep 7, 1995NoYesNoDISCNBRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE30aa966ab4f79b21911e07713e71ec9a366671345b7e65989224e5e86b7757e6
8307A209439001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATECIPLAEQ 15 UNITS BASE/VIALAP["AP"]2019-03-11Mar 11, 2019NoNoNoRXCIPLA LTDf10d497835d8b1d4a9dbbaf76e77fb9fc9c6b158910637ff55a7f91ed91b6587
8308A065185001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEFRESENIUS KABI USAEQ 15 UNITS BASE/VIALAP["AP"]2008-01-28Jan 28, 2008NoNoYesRXFRESENIUS KABI USA LLC82c504e013afbf65ce5fe2671ae2dcff14dec0575c7177d2f3e6756bcc7667bc
8309A065185002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEFRESENIUS KABI USAEQ 30 UNITS BASE/VIALAP["AP"]2008-01-28Jan 28, 2008NoNoYesRXFRESENIUS KABI USA LLC844e8c0859281312a30d92776ee00a625e30d0cc143879d9d5e60d6663c78afb
8310A065031001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEHOSPIRAEQ 15 UNITS BASE/VIALAP["AP"]2000-03-10Mar 10, 2000NoNoNoRXHOSPIRA INC78f2d6b3ab5eecbf02179889e0a42550477a2cd262d5ed5a3947352f51de3057
8311A065031002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEHOSPIRAEQ 30 UNITS BASE/VIALAP["AP"]2000-03-10Mar 10, 2000NoNoNoRXHOSPIRA INC8f08f76dbd8a8ceb8972f1d928eaef25683b50fda847ccc0d8014fa53162057a
8312A205030001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEMEITHEALEQ 15 UNITS BASE/VIALAP["AP"]2018-04-20Apr 20, 2018NoNoNoRXMEITHEAL PHARMACEUTICALS INCaa437790a86c956919ba0f1d6e163ba1d9cc5bfcfa8848d1aba4e694b16428b5
8313A205030002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEMEITHEALEQ 30 UNITS BASE/VIALAP["AP"]2018-04-20Apr 20, 2018NoNoNoRXMEITHEAL PHARMACEUTICALS INC6366a5666c2d549a81bfabb62ced6f644e73789d99f3ddb32db426927b4a5a78
8314A065201001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEPHARMACHEMIE BVEQ 15 UNITS BASE/VIAL[]2007-12-13Dec 13, 2007NoNoNoDISCNPHARMACHEMIE BV53895ee604e4da802c93c59276916a8badf730c43fde6983ec0f300f7b451ed6
8315A064084001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATETEVA PARENTERALEQ 15 UNITS BASE/VIAL[]1996-06-01Jun 1, 1996NoNoNoDISCNTEVA PARENTERAL MEDICINES INC38b15705f198dc7ff1f8e9864ffe43dc048338dfb48366bec155999917cb8b54
8316A064084002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATETEVA PARENTERALEQ 30 UNITS BASE/VIAL[]1996-06-01Jun 1, 1996NoNoNoDISCNTEVA PARENTERAL MEDICINES INCe59ef020ec72be754e5a7694090b8530486c4fbb1ea933c1490ecb8b5188f6c4
8317A065033001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATETEVA PHARMS USAEQ 15 UNITS BASE/VIALAP["AP"]2000-06-27Jun 27, 2000NoNoNoRXTEVA PHARMACEUTICALS USA0e77e92875d08a05aa32bf81bdeffa1d4b48dd5758c863c120bfb1cecda4be82
8318A065033002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATETEVA PHARMS USAEQ 30 UNITS BASE/VIALAP["AP"]2000-06-27Jun 27, 2000NoNoNoRXTEVA PHARMACEUTICALS USA9f28a7f9da9955bd35f8864581f5ce741ab9b9733aa8f779e33dbd5311ab674b
8319A065042002BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEWEST-WARD PHARMS INTEQ 15 UNITS BASE/VIALAP["AP"]2001-10-17Oct 17, 2001NoNoNoRXWEST-WARD PHARMACEUTICALS INTERNATIONAL LTD6f43658f38a6ab9f89900a5dec2a728c0bf99cdc5880dd759e3604f373029203
8320A065042001BLEOMYCIN SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBLEOMYCIN SULFATEWEST-WARD PHARMS INTEQ 30 UNITS BASE/VIALAP["AP"]2001-10-17Oct 17, 2001NoNoNoRXWEST-WARD PHARMACEUTICALS INTERNATIONAL LTD78b734a1f71a6607fab064adaf3759a45e4875b01433e0697946e00a2b90c8f9
8321N018678001AMINO ACIDSINJECTABLE;INJECTIONINJECTABLEINJECTIONBRANCHAMIN 4%BAXTER HLTHCARE4% (4GM/100ML)[]1984-09-28Sep 28, 1984NoNoNoDISCNBAXTER HEALTHCARE CORP0dc3b58844733fe96b4a27d3a8d83cabc30b8c5fbb0c101f8414068f000bd9f2
8322N018684001AMINO ACIDSINJECTABLE;INJECTIONINJECTABLEINJECTIONBRANCHAMIN 4% IN PLASTIC CONTAINERBAXTER HLTHCARE4% (4GM/100ML)[]1984-09-28Sep 28, 1984NoNoNoDISCNBAXTER HEALTHCARE CORPafe67817c062d5cf9f6e30dd98f0959d1e4ea227463f6bddcb5590ad4ae6fb20
8323N018571001TERBUTALINE SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETHINEPHARMACARE1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNPHARMACARE LTDe8574ca8fcbbc86053fcde1b42bd72aea3b544041123cfb5b134d985995e56ce
8324A070134001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEABRAXIS PHARM50MG/ML[]1986-04-29Apr 29, 1986NoNoNoDISCNABRAXIS PHARMACEUTICAL PRODUCTS3e268660da5ec356814af12e13a41049a5d2fc39c754c64db07c9cf72523e311
8325A071298001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEABRAXIS PHARM100MG/ML[]1987-02-13Feb 13, 1987NoNoNoDISCNABRAXIS PHARMACEUTICAL PRODUCTSa2cb8f82b1786ef5cb56cee2d5c9d1ea670b4332a4d2abf8a7c67ff9849c85ca
8326A071151001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEASTRAZENECA50MG/ML[]1987-08-10Aug 10, 1987NoNoNoDISCNASTRAZENECA LPb95d350569d6537c2526a0dd30aaa6f85ad6469ea45a117943dc40e4e353c0f3
8327A071152001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEASTRAZENECA50MG/ML[]1987-08-10Aug 10, 1987NoNoNoDISCNASTRAZENECA LPf07cf073aa57df24aadc735e607e59680b0a726cfecf907533274eaf953e1d13
8328A071153001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEASTRAZENECA50MG/ML[]1987-08-10Aug 10, 1987NoNoNoDISCNASTRAZENECA LP83f51e83b2596536b6c2b2d81bbc953b28baaa5d0427da003eb642bef6bf6727
8329A204386001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEBRECKENRIDGE50MG/ML[]2018-12-21Dec 21, 2018NoNoYesRXBRECKENRIDGE PHARMACEUTICAL INCddb01533134ea717de390f1c918f39fd4486295645ae5f218a63c73f98b33816
8330A070546001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEEUROHLTH INTL SARL50MG/ML[]1986-05-14May 14, 1986NoNoNoDISCNEUROHEALTH INTERNATIONAL SARL63790773ffcdbf0af5701e6b34f9d54397a822f428fe4ccafe8a7705536896d5
8331N019030001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEHOSPIRA50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1986-04-29Apr 29, 1986NoYesNoDISCNHOSPIRA WORLDWIDE, INC6f6e06d7aed910af04e95ce738a20849c3c48eca5f89891c5b0ad47216a7bf6b
8332N019033001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEHOSPIRA50MG/ML[]1986-04-29Apr 29, 1986NoNoNoDISCNHOSPIRA INC8f8b0fa76645a8cb67a6a4445376e29c7fd78d2d03d3765ae9458b3b626c2f68
8333A070119001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEINTL MEDICATION50MG/ML[]1986-04-29Apr 29, 1986NoNoNoDISCNINTERNATIONAL MEDICATION SYSTEM5bfcc1480a6c13ef24daa2cdd268e5de928efcc58873725fbb67784df6f21046
8334A070891001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATELUITPOLD50MG/ML[]1988-07-26Jul 26, 1988NoNoNoDISCNLUITPOLD PHARMACEUTICALS INC1b856f5cf0a3dde4edebf1398413584cf43ce0fad5870f68fca98ad2a9f02421
8335A070545001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATEWEST-WARD PHARMS INT50MG/ML[]1986-05-14May 14, 1986NoNoNoDISCNWEST-WARD PHARMACEUTICALS INTERNATIONAL LTD955548f4bcceca1e3d61c4f53e07722ba737efdb0edb9e6415f17e5cb6cd3c22
8336N019005002BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5%ABBOTT200MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVae0ea3c030233a4c9eddddaa7547ed3ca0b5ea0a8df134ac900ae091f52eeace
8337N019005003BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5%ABBOTT400MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV653ea9296df331e20e07e69ab12d7ec12315407b20e398de0e005e6ffa249d28
8338N019005001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5%ABBOTT800MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV498ed2602b2fbb609e5d8d662d79411c318d8b80d29b41729d19d45e70da4995
8339N019121001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERB BRAUN100MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNB BRAUN MEDICAL INC4e7ffb3369cd4895307dc0d3d26191922c8ef1ecba75d351a05a0362d4196c78
8340N019121002BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERB BRAUN200MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNB BRAUN MEDICAL INCf6202e15f8ee4122e75538458c74e9f45a87ec256182dfa5dfec2da94b57f271
8341N019121003BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERB BRAUN400MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNB BRAUN MEDICAL INCd2e2a3d5f13d30d1c6648a6c6e31519474bbfe0015a64acbe302bf3790775b75
8342N019837002BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERBAXTER HLTHCARE200MG/100ML[]1989-04-12Apr 12, 1989NoNoNoDISCNBAXTER HEALTHCARE CORP7da4f2573296e6227fa6f9dad044755ce9cc883732aa55017bce8e49f74ed5cd
8343N019837001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERBAXTER HLTHCARE400MG/100ML[]1989-04-12Apr 12, 1989NoNoNoDISCNBAXTER HEALTHCARE CORP52fa4d4ee358b9bafa0758f2bec54f2da54d0117c39374579b6df2237e270030
8344N019008002BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERHOSPIRA INC200MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNHOSPIRA INC4071b348360dd1f82cb93266739f2fa1d4129d89baec80d3c230075457cbf155
8345N019008003BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERHOSPIRA INC400MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNHOSPIRA INC2286fcc0e838fc6239a8f12001cd6ef1c741c2e789759d054f313c68b51136f5
8346N019008001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERHOSPIRA INC800MG/100ML[]1986-04-29Apr 29, 1986NoNoNoDISCNHOSPIRA INC4b4aab4ac5d404c84b08c3793aaf61ad5a8180fa74f303983958b853d06e136b
8347N017954001BRETYLIUM TOSYLATEINJECTABLE;INJECTIONINJECTABLEINJECTIONBRETYLOLHOSPIRA50MG/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNHOSPIRA INC84b4baffe75f18c7c966f4d2a97591f02e4984bcfa411e77199789a6ac32698f
8348N019386003ESMOLOL HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONBREVIBLOCBAXTER HLTHCARE10MG/ML[]1988-08-15Aug 15, 1988NoNoNoDISCNBAXTER HEALTHCARE CORPd2215a45edcf160379f73fae51dca50fe2451a6320a2dabdfb76102e3b6b74ed
8349N019386006ESMOLOL HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONBREVIBLOCBAXTER HLTHCARE10MG/MLAP["AP"]2003-02-25Feb 25, 2003NoYesYesRXBAXTER HEALTHCARE CORPb3137e7752da18abd1e688f7e36a1272a760fa5e9c7b172e70b0f468e931cc0b
8350N019386007ESMOLOL HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONBREVIBLOCBAXTER HLTHCARE20MG/ML[]2003-05-28May 28, 2003NoNoNoDISCNBAXTER HEALTHCARE CORP109bec0aa268406c3bc9c69147c013ca0685048553fc971dc669eef6bbcf9a87
8351N019386005ESMOLOL HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONBREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINERBAXTER HLTHCARE2GM/100ML[]2003-01-27Jan 27, 2003NoYesYesRXBAXTER HEALTHCARE CORP2def18932c0bdb4f379b1f97159627c745784fd38553f2b00d5416fb62afb4a4